Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    TECELRA

    • Home
    • TECELRA
    A gloved hand holds a clear petri dish near a microscope in a bright laboratory setting, suggesting scientific research or experiment.
    Healthcare, Latest News, Research

    UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    January 21, 2026 ayushis Comments Off on UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    UI Health Care has begun treating eligible patients with synovial sarcoma using a new form of immunotherapy known as T cell receptor (TCR) therapy. This treatment approach represents an important step forward in expanding access to innovative options for people facing advanced synovial sarcoma. A targeted immune-based approach TCR therapy is designed to help the […]

    A scientist wearing protective clothing, a mask, and safety glasses looks through a microscope in a laboratory setting, with a pen in hand and focused on her research.
    Research

    Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment

    December 12, 2025 joshs Comments Off on Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment

    In a groundbreaking advancement in cancer treatment, a patient with synovial sarcoma in Arizona has become the first in the state to receive a cutting-edge immune-cell therapy, TECELRA, at the HonorHealth Research Institute in Scottsdale. Synovial sarcoma is a rare soft-tissue cancer that primarily affects large joints in the arms and legs, though it can […]

    Search

    Categories

    • Black Flag Racing (2)
    • Case Study (1)
    • Children (1)
    • CHOP (3)
    • Development (2)
    • Dr. Theodore Laetsch (3)
    • Education (4)
    • Healthcare (3)
    • Latest News (7)
    • Research (13)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • Black and white photo of a baby's legs and feet resting on a soft blanket, with the focus on the feet and toes. The background and upper body are blurred.
      Synovial Sarcoma of the Parotid Gland in Infancy: A Rare Case Study
    • Two surgeons wearing surgical masks and caps focus intently on a procedure under bright operating room lights, with another medical professional visible in the background.
      Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study
    • A gloved hand holds a clear petri dish near a microscope in a bright laboratory setting, suggesting scientific research or experiment.
      UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    Tags

    Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Case Study Chase Spence Chas Spence CHOP Community Engagement & Partnerships Manager Dr. Rachel Hurly Dr. Ted Laetsch fibroblast fibroblast epigenome ground breaking human cell therapy immune-cell therapy Infant innovate treaments JAMA Internal Medicine Julie Kramer MAGE-A4 Monophasic Synovial Sarcoma Nathan Imperiale National Tumor Board Nature Communications Parotid Gland Patient Stories Pediatric Oncology Penn Medicine Penn Medicine Synovial Sarcoma Foundation Prasterone Rare Cancer rare disease research Sarcoma Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment TCR-NK TCR Therapy TECELRA Zelluna ZI-MA4-1

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch